Yves Landry

5.2k total citations
141 papers, 4.4k citations indexed

About

Yves Landry is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yves Landry has authored 141 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 42 papers in Immunology and 32 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yves Landry's work include Mast cells and histamine (39 papers), Receptor Mechanisms and Signaling (35 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (27 papers). Yves Landry is often cited by papers focused on Mast cells and histamine (39 papers), Receptor Mechanisms and Signaling (35 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (27 papers). Yves Landry collaborates with scholars based in France, Canada and United States. Yves Landry's co-authors include Christian Bronner, Marc Mousli, Jean‐Luc Bueb, J.-P. Gies, B. Rouot, Jean‐Pierre Gies, Eric Tschirhart, Joël Bockaert, Bruno Rouot and Nelly Frossard and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Yves Landry

134 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yves Landry France 34 2.4k 1.2k 940 834 399 141 4.4k
Maurice B. Feinstein United States 40 2.8k 1.2× 453 0.4× 570 0.6× 834 1.0× 245 0.6× 87 4.8k
F. Merlin Bumpus United States 43 3.3k 1.3× 707 0.6× 703 0.7× 709 0.9× 558 1.4× 163 7.6k
Ruth M. Kramer United States 34 3.5k 1.4× 573 0.5× 333 0.4× 837 1.0× 227 0.6× 54 5.4k
Ronald L. Magolda United States 29 3.0k 1.2× 728 0.6× 480 0.5× 493 0.6× 131 0.3× 69 5.6k
James D. Clark United States 34 3.2k 1.3× 1.3k 1.0× 429 0.5× 979 1.2× 302 0.8× 77 6.3k
Thaddeus F. Molski United States 33 2.3k 0.9× 1.3k 1.1× 643 0.7× 619 0.7× 64 0.2× 83 4.2k
Hervé Coste France 16 3.5k 1.4× 527 0.4× 494 0.5× 550 0.7× 102 0.3× 17 4.8k
Nigel P. Shankley United States 26 1.6k 0.7× 767 0.6× 832 0.9× 610 0.7× 116 0.3× 84 2.9k
David T. Dudley United States 24 5.6k 2.3× 1.1k 0.9× 1.0k 1.1× 867 1.0× 247 0.6× 39 8.6k
Alaina J. Ammit Australia 42 2.1k 0.9× 1.5k 1.2× 298 0.3× 1.7k 2.0× 129 0.3× 123 5.7k

Countries citing papers authored by Yves Landry

Since Specialization
Citations

This map shows the geographic impact of Yves Landry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Landry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Landry more than expected).

Fields of papers citing papers by Yves Landry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Landry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Landry. The network helps show where Yves Landry may publish in the future.

Co-authorship network of co-authors of Yves Landry

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Landry. A scholar is included among the top collaborators of Yves Landry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Landry. Yves Landry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sick, Émilie, Nathalie Niederhoffer, K. Takeda, Yves Landry, & J.-P. Gies. (2009). Activation of CD47 receptors causes histamine secretion from mast cells. Cellular and Molecular Life Sciences. 66(7). 1271–1282. 24 indexed citations
2.
Kamel, Rehab, et al.. (2002). G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides. 23(8). 1507–1515. 121 indexed citations
3.
4.
Daeffler, Laurent & Yves Landry. (2000). Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential. Fundamental and Clinical Pharmacology. 14(2). 73–87. 26 indexed citations
5.
Schmidlin, Fabien, et al.. (2000). PLA2 phosphorylation and cyclooxygenase-2 induction, through p38 MAP kinase pathway, is involved in the IL-1β-induced bradykinin B2 receptor gene transcription. Naunyn-Schmiedeberg s Archives of Pharmacology. 361(3). 247–254. 21 indexed citations
6.
Scherrer, Didier, et al.. (1997). Glucocorticoid modulation of muscarinic and β‐adrenergic receptors in guinea pig lung. Fundamental and Clinical Pharmacology. 11(2). 111–116. 12 indexed citations
7.
Mousli, Marc, et al.. (1995). Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells. Inflammation Research. 44(S1). S26–S27. 3 indexed citations
8.
Mousli, Marc, et al.. (1995). Structural requirements for neuropeptide Y in mast cell and G protein activation. European Journal of Pharmacology Molecular Pharmacology. 289(1). 125–133. 34 indexed citations
9.
Trifilieff, Alexandre, et al.. (1994). Co-solubilization of bradykinin B2 receptors and angiotensin-converting enzyme from guinea pig lung membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1191(1). 109–116. 7 indexed citations
10.
Amrani, Yassine, et al.. (1993). Comparative action of new highly potent bradykinin receptor antagonists in the guinea-pig trachea. European Journal of Pharmacology. 239(1-3). 227–229. 21 indexed citations
11.
Fischer, T, Christian Bronner, Yves Landry, & Marc Mousli. (1993). The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1176(3). 305–312. 24 indexed citations
12.
Landry, Yves. (1991). Evidences for a regulating role of intracellular polyamines in the interaction of g proteins with receptors. Fundamental and Clinical Pharmacology. 5(5). 459. 2 indexed citations
13.
Trifilieff, Alexandre, et al.. (1991). High-affinity receptors for bombesin-like peptides in normal guinea pig lung membranes. Life Sciences. 48(26). 2571–2578. 6 indexed citations
14.
Trifilieff, Alexandre, El‐Bdaoui Haddad, Yves Landry, & Jean‐Pierre Gies. (1991). Evidence for two high-affinity bradykinin binding sites in the guinea-pig lung. European Journal of Pharmacology Molecular Pharmacology. 207(2). 129–134. 25 indexed citations
15.
Mousli, Marc, Christian Bronner, Yves Landry, Joël Bockaert, & B. Rouot. (1990). Direct activation of GTP‐binding regulatory proteins (G‐proteins) by substance P and compound 48/80. FEBS Letters. 259(2). 260–262. 262 indexed citations
16.
Mousli, Marc, Christian Bronner, Joël Bockaert, B. Rouot, & Yves Landry. (1990). Interaction of substance P, compound 4880 and mastoparan with the α-subunit C-terminus of G protein. Immunology Letters. 25(4). 355–357. 158 indexed citations
17.
Landry, Yves. (1988). Bibliographie courante sur l'histoire de la population canadienne et la demographie historique au Canada, 1987 | A Current Bibliography on the History of Canadian Population and Historical Demography in Canada, 1987. Histoire sociale. 21(42).
18.
Gies, Jean‐Pierre & Yves Landry. (1988). Sialic acid is selectively involved in the interaction of agonists with M2 muscarinic acetylcholine receptors. Biochemical and Biophysical Research Communications. 150(2). 673–680. 18 indexed citations
19.
Gies, Jean‐Pierre, Brigitte Ilien, & Yves Landry. (1987). Temperature-dependence and heterogeneity of muscarinic agonist and antagonist binding. Biochemical Pharmacology. 36(16). 2589–2597. 13 indexed citations
20.
Landry, Yves. (1984). Le cycle de vie familiale en Nouvelle-France : méthodologie et application à un échantillon. Histoire sociale. 17(33). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurice B. Feinstein Breakdown of academic impact, for papers by F. Merlin Bumpus Breakdown of academic impact, for papers by Ruth M. Kramer Breakdown of academic impact, for papers by Ronald L. Magolda Breakdown of academic impact, for papers by James D. Clark Breakdown of academic impact, for papers by Thaddeus F. Molski Breakdown of academic impact, for papers by Hervé Coste Breakdown of academic impact, for papers by Nigel P. Shankley Breakdown of academic impact, for papers by David T. Dudley Breakdown of academic impact, for papers by Alaina J. Ammit
Rankless by CCL
2026